| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680538 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2017 | 6 Pages |
Abstract
Increasing the access of valuable anonymized patient-level clinical trial data has the potential to inform the foundational and regulatory science required to deliver innovative treatments for AD.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ann M. Hake, Penny A. Dacks, Stephen P. ArneriÄ, CAMD ICF working group CAMD ICF working group,